Mutation of the ZKSCAN3 binding site in the promoter caused the activity of colon cancer cells to plummet (to 29.9% and 14.3% in DLD1 and T84 cell lines, respectively), whereas the activity of hepatocytes only decreased to 71.6% [54]. Here, ZKSCAN3 is linked to colonic neoplasm.